Literature DB >> 1648595

Ki-1-positive anaplastic large-cell lymphoma: a clinicopathologic entity?

M E Kadin.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1648595     DOI: 10.1200/JCO.1991.9.4.533

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).

Authors:  G W Colleoni; J A Bridge; B Garicochea; J Liu; D A Filippa; M Ladanyi
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Arthritis as a presenting feature of non-Hodgkin's lymphoma.

Authors:  F Falcini; M Bardare; R Cimaz; A Lippi; F Corona
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

3.  MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma.

Authors:  C Marosi; R Heinz; G Steger; A Fortelny; A Chott; H Hanak; T Radaszkiewicz; M Baur; G Kreiner; I Schwarzinger
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Combination of dexamethasone, high-dose cytarabine, and carboplatin is effective for advanced large-cell non-Hodgkin lymphoma of childhood.

Authors:  John T Sandlund; Victor M Santana; Melissa M Hudson; Mihaela Onciu; David Head; Daryl J Murry; Raul Ribeiro; Dana Wallace; Renee Rencher; Ching-Hon Pui
Journal:  Cancer       Date:  2008-08-15       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.